The China Hyaluronic Acid Injection Market was valued at an estimated USD 780 Million in 2024 and is projected to reach approximately USD 1.3 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of around 9.5% during the forecast period (2024–2030). This robust growth is fueled by rising disposable incomes, increasing aesthetic consciousness, advancements in product technology, and the expanding adoption of non-surgical cosmetic procedures among China’s vast population.

As the aesthetic medicine industry in China continues its rapid expansion, the market is defined by a competitive landscape of both domestic powerhouses and multinational corporations. These companies are driving innovation in product safety, efficacy, and application diversity. In this blog, we profile the Top 10 Companies in the China Hyaluronic Acid Injection Market—a mix of established global leaders and ambitious local champions shaping the future of beauty and wellness in the region.

Download FREE Sample Report: China Hyaluronic Acid Injection Market – View in Detailed Research Report

---

🔟 1. Allergan (an AbbVie company)

Headquarters: Dublin, Ireland (Global), with significant operations in Shanghai, China
Key Offering: JUVÉDERM® range of fillers

Allergan, now part of AbbVie, remains a dominant global force in medical aesthetics. Its JUVÉDERM collection is one of the most recognized and trusted hyaluronic acid filler brands worldwide, including in China. The company invests heavily in physician training and consumer education, solidifying its premium positioning.

Innovation and Market Initiatives:

• Extensive portfolio for volumizing, contouring, and smoothing

• Strong focus on clinical research and regulatory compliance

• Strategic marketing partnerships with key opinion leaders in Chinese aesthetics

---

9️⃣ 2. Galderma

Headquarters: Lausanne, Switzerland
Key Offering: RESTYLANE® and RESTYLANE SKINBOOSTERS™

Galderma is a pure-play dermatology company with a significant presence in China. Its RESTYLANE line, based on NASHA™ technology, is renowned for its high product quality and natural-looking results, making it a preferred choice for many practitioners and patients across the country.

Innovation and Market Initiatives:

• Focus on tailored treatments for diverse facial areas and aging concerns

• Commitment to scientific education and training for dermatologists

---

8️⃣ 3. Bloomage BioTechnology Corporation Limited

Headquarters: Jinan, Shandong, China
Key Offering: “Cytocare / Singfiller” and other HA-based dermal fillers

Bloomage BioTechnology is a Chinese biotech leader and the world’s largest producer of hyaluronic acid raw materials. This vertical integration gives it a significant cost and supply chain advantage. Its aesthetic division markets a range of fillers that are highly competitive in the domestic market.

Innovation and Market Initiatives:

• World-leading HA manufacturing capacity and R&D

• Aggressive expansion of its branded filler portfolio in China

• Focus on developing next-generation bio-functional HA products

Download FREE Sample Report: China Hyaluronic Acid Injection Market – View in Detailed Research Report

---

7️⃣ 4. Beijing IMEIK Technology Development Co., Ltd.

Headquarters: Beijing, China
Key Offering: “Elasty” and “Faciald” series of dermal fillers

IMEIK is one of China’s most prominent domestic manufacturers of aesthetic medical products. It has built a strong reputation for quality and has a vast distribution network covering thousands of medical aesthetic institutions nationwide, making it a formidable local competitor.

Innovation and Market Initiatives:

• Comprehensive product portfolio covering various indications

• Extensive training and support system for clinics

• Continuous investment in R&D for new formulations

---

6️⃣ 5. Haohai Biological Technology Co., Ltd.

Headquarters: Chengdu, Sichuan, China
Key Offering: “Hyaluron” series of dermal fillers

Haohai BioTech is a leading integrated player in the global HA industry, involved in research, production, and sales. Its ophthalmologic products are well-established, and it has been strategically expanding its aesthetic medicine division within China, leveraging its core expertise in biopharmaceuticals.

Innovation and Market Initiatives:

• Strong R&D capabilities in biomedical materials

• Focus on producing high-purity, clinically proven HA fillers

• Expanding market share through competitive pricing and quality

---

5️⃣ 6. HUGEL, Inc.

Headquarters: Seoul, South Korea
Key Offering: “Well-age” and “Chaeum” filler series

HUGEL is a major South Korean player that has successfully penetrated the Chinese market, capitalizing on the strong influence of K-beauty trends. The company is known for its botulinum toxin and has a growing portfolio of HA dermal fillers tailored for Asian facial anatomy and aesthetic preferences.

Innovation and Market Initiatives:

• Leveraging the popularity and trust in Korean aesthetic technology

• Strategic partnerships and distribution agreements in China

• Products designed specifically for subtle, natural enhancement favored in Asia

---

4️⃣ 7. Merz Aesthetics

Headquarters: Frankfurt, Germany
Key Offering: Belotero® range of fillers

Merz Aesthetics is a global specialist in aesthetic and neurotoxin products. Its Belotero portfolio, characterized by its cohesive polydensified matrix technology, offers unique advantages for treating fine lines and delicate areas, giving it a distinct position in the competitive Chinese market.

Innovation and Market Initiatives:

• Product differentiation through specialized technology

• Comprehensive approach to facial aesthetics with complementary products

• Strong emphasis on physician-led training and patient safety

Download FREE Sample Report: China Hyaluronic Acid Injection Market – View in Detailed Research Report

---

3️⃣ 8. Croma-Pharma GmbH

Headquarters: Vienna, Austria
Key Offering: Princess® range of fillers

Croma is a European family-owned company with a growing international footprint. Its Princess® fillers are known for their high-quality standards and are steadily gaining recognition among Chinese practitioners seeking reliable European alternatives with a strong safety profile.

Innovation and Market Initiatives:

• Proven track record of safety and efficacy in Europe

• Strategic entry and brand-building initiatives in the Chinese market

• Focus on building trust through transparency and education

---

2️⃣ 9. Sinclair Pharma (now part of Advanz Pharma)

Headquarters: London, UK
Key Offering: Perfectha® range of fillers

Sinclair Pharma, now under Advanz Pharma, has a long history in the dermal filler market. Perfectha® is a well-established brand with a presence in over 70 countries, including China. Its products are based on a resilient cross-linked HA gel, appealing to a segment of the market looking for durable results.

Innovation and Market Initiatives:

• Global brand recognition and extensive clinical data

• Focus on providing a balance between longevity and natural feel

• Adapting its global strategy to meet specific regulatory and market demands in China

---

1️⃣ 10. Suneva Medical (a partner with local distributors)

Headquarters: San Diego, California, USA
Key Offering: Artefill®/Artecoll® (HA-based and other fillers)

While Suneva Medical is a U.S.-based company, its innovative aesthetic products, often distributed through local partners, have a presence in the Chinese market. The company focuses on longer-lasting and regenerative aesthetic solutions, targeting a niche but growing segment of consumers seeking more durable outcomes beyond traditional HA.

Innovation and Market Initiatives:

• Pioneering longer-lasting dermal filler technologies

• Strategic partnerships with established distributors in China

• Targeting the premium segment of the market with innovative solutions

Read Full Report: China Hyaluronic Acid Injection Market – View in Detailed Research Report

---

🌟 Outlook: The Future of China’s Hyaluronic Acid Market is Personalized and High-Tech

The China Hyaluronic Acid Injection Market is undergoing a significant evolution. Driven by strong consumer demand, the competitive landscape is shifting towards greater product differentiation, technological sophistication, and personalized treatment approaches. The dominance of international brands is being challenged by highly capable domestic manufacturers who are rapidly closing the technology gap.

📈 Key Trends Shaping the Market:

• Rise of domestic brands leveraging local manufacturing and cost advantages.

• Increasing demand for tailored formulations for specific facial areas and ethnic characteristics.

• Growing integration of digital tools for treatment planning and patient engagement.

• Stronger regulatory oversight fostering a more standardized and safer market environment.

Read Full Report: China Hyaluronic Acid Injection Market – View in Detailed Research Report

The companies profiled are not only competing for market share—they are collectively elevating the standards of aesthetic medicine and expanding access to safe, effective cosmetic treatments for millions in China.